AMD
Phase 1
TrialWire’s AI-Match Platform was engaged by the sponsor at the recommendation of a regional CRO.
We were brought in as a study rescue solution and worked alongside the CRO and 5 sites in Australia and New Zealand to deliver patients.
All patent engagement activity was funneled through the AI-Match Platform so patients could be quickly online screened and connected to their nearest site for follow-up.
The study was recruited on time and on budget.
